help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fulton, S. A.
Right arrow Articles by Henry Boom, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fulton, S. A.
Right arrow Articles by Henry Boom, W.

Am. J. Respir. Cell Mol. Biol., Volume 22, Number 3, March, 2000 333-343

Pulmonary Immune Responses during Primary Mycobacterium bovis- Calmette-Guerin Bacillus Infection in C57Bl/6 Mice

Scott A. Fulton, Thomas D. Martin, Raymond W. Redline, and W. Henry Boom

Division of Infectious Diseases and the Institute of Pathology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio

Mechanisms of protective immunity to mycobacterial infection in the lung remain poorly defined. In this study, T-cell subset expansion and cytokine expression in bronchoalveolar spaces, lung parenchyma, and mediastinal lymph nodes of mice infected intratracheally with Mycobacterium bovis-Calmette-Guerin bacillus (BCG) were analyzed in parallel with histopathology and bacterial burden. M. bovis-BCG was cleared rapidly from bronchoalveolar spaces without evidence for persistence. In lung parenchyma bacteria grew during the first 4 wk followed by gradual clearance with less than 0.1% of the original inoculum persisting for more than 8 mo. Clearance of M. bovis-BCG from bronchoalveolar lavage was associated with recruitment of both neutrophils and lymphocytes. Lung CD4+, CD8+, and gamma delta T-cell receptor-positive T cells expanded maximally by Week 4, and declined by Week 8 to control values despite bacterial persistence. Both CD4+ and CD8+ lung T cells produced interferon (IFN)-gamma in response to M. bovis-BCG. Four distinct pathologic states of lung parenchymal infection were noted. Early focal sub-bronchial inflammation with transmigration of cells into airways was followed by diffuse peribronchitis, perivasculitis, and alveolitis with activated macrophages, lymphoblasts, and occasional giant cells. The latter stage corresponded to maximal M. bovis-BCG growth. Resolving infection consisted of small lymphocytes and foamy macrophages, which coincided with decreasing M. bovis-BCG colony-forming units, T-cell infiltration, and IFN-gamma expression. A final quiescent phase consisted of residual lymphoid aggregates and perivasculitis associated with persistent spontaneous IFN-gamma production. Bacterial dissemination to lymph node and spleen occurred by Week 4 and declined in parallel to lung. In contrast to lung, IFN-gamma secretion was detected only late despite early expansion of CD4+ and CD8+ T cells. By reverse transcriptase/polymerase chain reaction, IFN-gamma and interleukin (IL)-12 p40 messenger RNA (mRNA) in lung paralleled IFN-gamma protein production. Tumor necrosis factor-alpha , IL-4 and IL-10 mRNA expression was not increased during M. bovis-BCG lung infection. Thus, protective immunity to M. bovis-BCG in the lung evolved differently in air space, lung, and lymph node.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. M. Anis, S. A. Fulton, S. M. Reba, C. V. Harding, and W. H. Boom
Modulation of Naive CD4+ T-Cell Responses to an Airway Antigen during Pulmonary Mycobacterial Infection
Infect. Immun., May 1, 2007; 75(5): 2260 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Ngai, S. McCormick, C. Small, X. Zhang, A. Zganiacz, N. Aoki, and Z. Xing
Gamma Interferon Responses of CD4 and CD8 T-Cell Subsets Are Quantitatively Different and Independent of Each Other during Pulmonary Mycobacterium bovis BCG Infection
Infect. Immun., May 1, 2007; 75(5): 2244 - 2252.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Ordway, M. Harton, M. Henao-Tamayo, R. Montoya, I. M. Orme, and M. Gonzalez-Juarrero
Enhanced Macrophage Activity in Granulomatous Lesions of Immune Mice Challenged with Mycobacterium tuberculosis.
J. Immunol., April 15, 2006; 176(8): 4931 - 4939.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. A. Fulton, S. M. Reba, R. K. Pai, M. Pennini, M. Torres, C. V. Harding, and W. H. Boom
Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein
Infect. Immun., April 1, 2004; 72(4): 2101 - 2110.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. K. Saxena, Q. B. Saxena, D. N. Weissman, J. P. Simpson, T. A. Bledsoe, and D. M. Lewis
Effect of Diesel Exhaust Particulate on Bacillus Calmette-Guerin Lung Infection in Mice and Attendant Changes in Lung Interstitial Lymphoid Subpopulations and IFN{gamma} Response
Toxicol. Sci., May 1, 2003; 73(1): 66 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Dieli, J. Ivanyi, P. Marsh, A. Williams, I. Naylor, G. Sireci, N. Caccamo, C. Di Sano, and A. Salerno
Characterization of Lung {gamma}{delta} T Cells Following Intranasal Infection with Mycobacterium bovis Bacillus Calmette-Guerin
J. Immunol., January 1, 2003; 170(1): 463 - 469.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. A. Fulton, S. M. Reba, T. D. Martin, and W. H. Boom
Neutrophil-Mediated Mycobacteriocidal Immunity in the Lung during Mycobacterium bovis BCG Infection in C57BL/6 Mice
Infect. Immun., September 1, 2002; 70(9): 5322 - 5327.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Neufert, R. K. Pai, E. H. Noss, M. Berger, W. H. Boom, and C. V. Harding
Mycobacterium tuberculosis 19-kDa Lipoprotein Promotes Neutrophil Activation
J. Immunol., August 1, 2001; 167(3): 1542 - 1549.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. A. Wilkinson, T. D. Martin, S. M. Reba, H. Aung, R. W. Redline, W. H. Boom, Z. Toossi, and S. A. Fulton
Latency-Associated Peptide of Transforming Growth Factor beta Enhances Mycobacteriocidal Immunity in the Lung during Mycobacterium bovis BCG Infection in C57BL/6 Mice
Infect. Immun., November 1, 2000; 68(11): 6505 - 6508.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.